Factor This Power Engineering
Live Events
DTECH® Events
POWERGEN™
INFOCAST Events
Calendar
Webinars
Podcasts
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
POWERGEN™
INFOCAST Events
Podcasts
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Aura Biosciences, Inc. - Common Stock
(NQ:
AURA
)
7.710
+0.240 (+3.21%)
Streaming Delayed Price
Updated: 3:31 PM EDT, May 21, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aura Biosciences, Inc. - Common Stock
< Previous
1
2
3
4
Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
November 07, 2023
It's time for another dive into the biggest pre-market stock movers as we break down all of the latest news for Tuesday morning.
Via
InvestorPlace
Sanmina, Adtran, Ameresco And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
↗
November 07, 2023
U.S. stock futures traded lower this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Aura Biosciences Announces Pricing of Public Offering of Common Stock
November 06, 2023
From
Aura Biosciences, Inc.
Via
Business Wire
Recap: Aura Biosciences Q1 Earnings
↗
May 11, 2023
Via
Benzinga
Aura Biosciences Releases Data Presentation Of Eye Cancer Candidate
↗
February 16, 2023
Via
Benzinga
Why Shares of Aura Biosciences Jumped This Week
↗
February 10, 2023
The clinical-stage biotech may be ready to release updated phase 3 trial results on its lead therapy.
Via
The Motley Fool
12 Health Care Stocks Moving In Monday's After-Market Session
↗
November 06, 2023
Via
Benzinga
Aura Biosciences Announces Proposed Public Offering of Common Stock
November 06, 2023
From
Aura Biosciences, Inc.
Via
Business Wire
Aura Biosciences Receives FDA Agreement Under Special Protocol Assessment (SPA) for CoMpass Phase 3 Clinical Trial of Belzupacap Sarotalocan (Bel-sar) in Early-stage Choroidal Melanoma
November 06, 2023
From
Aura Biosciences, Inc.
Via
Business Wire
Top 5 Health Care Stocks That May Fall Off A Cliff This Month
↗
November 06, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Aura Biosciences to Present Updated Phase 2 Data Evaluating Suprachoroidal Administration of Belzupacap Sarotalocan (Bel-sar) for the First-Line Treatment of Patients with Early-Stage Choroidal Melanoma at AAO 2023
October 31, 2023
From
Aura Biosciences Inc.
Via
Business Wire
Aura Biosciences Strengthens and Expands Leadership Team with Key Appointments
October 02, 2023
From
Aura Biosciences Inc.
Via
Business Wire
Aura Biosciences Reports Second Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights
August 09, 2023
From
Aura Biosciences Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023
↗
July 27, 2023
Via
Benzinga
Aura Biosciences to Participate in Upcoming Investor Conferences
May 24, 2023
From
Aura Biosciences Inc.
Via
Business Wire
Aura Biosciences to Participate in the JMP Securities Life Sciences Conference
May 12, 2023
From
Aura Biosciences Inc.
Via
Business Wire
Aura Biosciences Reports First Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights
May 11, 2023
From
Aura Biosciences Inc.
Via
Business Wire
Aura Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Development and Operational Highlights
March 15, 2023
From
Aura Biosciences Inc.
Via
Business Wire
Aura Biosciences Announces Positive Interim Phase 2 Safety and Efficacy Data of Belzupacap Sarotalocan (Bel-sar) for the First-Line Treatment of Patients with Early-Stage Choroidal Melanoma with Suprachoroidal Administration
February 16, 2023
From
Aura Biosciences, Inc.
Via
Business Wire
Aura Biosciences to Participate in Upcoming Investor Conferences
February 09, 2023
From
Aura Biosciences Inc.
Via
Business Wire
$49.5 Million Bet On Howard Hughes? Check Out These 4 Stocks Insiders Are Buying
↗
December 08, 2022
Although US stocks closed mostly lower on Wednesday, there were a few notable insider trades.
Via
Benzinga
Why Dollar General Shares Are Trading Lower By Over 8%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
↗
December 01, 2022
Gainers Top Ships Inc. (NASDAQ: TOPS) shares jumped 74% to $5.24. Vapotherm, Inc. (NASDAQ: VAPO) gained 48.8% to $1.3250.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
December 01, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
December 01, 2022
Via
Benzinga
Aura Biosciences Announces Pricing of Public Offering of Common Stock
November 30, 2022
From
Aura Biosciences, Inc.
Via
Business Wire
Aura Biosciences Announces Proposed Public Offering of Common Stock
November 30, 2022
From
Aura Biosciences, Inc.
Via
Business Wire
Aura Biosciences Reports Third Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
November 10, 2022
From
Aura Biosciences
Via
Business Wire
Aura Announces Global Phase 3 Trial Design with Suprachoroidal Route of Administration Based on Positive Phase 2 Interim Data of Belzupacap Sarotalocan in Early-Stage Choroidal Melanoma
November 10, 2022
From
Aura Biosciences, Inc.
Via
Business Wire
Aura Biosciences to Participate in Upcoming Investor Conferences
November 03, 2022
From
Aura Biosciences Inc.
Via
Business Wire
Tesla, ABB And Other Big Losers From Monday
↗
October 04, 2022
U.S. stocks closed sharply higher with the Dow Jones jumping more than 750 points on Monday. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
